Watson Wendy - Vaccine Research and Development, Pfizer, Inc

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 43 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Piotr Korbal,Jacek Wysocki,Teresa Jackowska,Mary Kline,Noor Tamimi,Jelena Drozd,Lanyu Lei,Yahong Peng,Peter C. Giardina,William Gruber,Daniel Scott,Wendy Watson

The Pediatric Infectious Disease Journalno. 6 (2024): 587-595

引用0浏览0WOS引用

Variation in Incidence Rates of Outcomes Relevant to Vaccine Safety Monitoring in a US Commercially Insured Population by Case Identification Algorithm

Christopher L. Crowe,Jill Dreyfus,Stephan Lanes,Haechung Chung,Wendy Watson

VACCINEno. 18 (2024): 3811-3818

引用0浏览0WOS引用

A Phase 3 Randomized Study to Evaluate Safety and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants

Yasunori Ishihara,Mitsuru Fukazawa, Shinya Enomoto,Richard de Solom,Masako Yamaji,Mary Kline,Masakazu Aizawa,Yahong Peng,Osamu Kogawara,Peter C. Giardina,Noor Tamimi,William C. Gruber,Wendy Watson

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2024)

引用0浏览0WOS引用

Safety of a 4-Dose 20-Valent Pneumococcal Conjugate Vaccine Series in Infants: A Randomized Trial

Gabriella Hajdu, Teena Hughes, G Laïssa Ouedraogo, Laurence Flint,Mariano Young, Vrunda Parikh,Dung-Yang Lee,Yahong Peng,William C Gruber,Daniel A Scott,Wendy Watson

Pediatrics（2024）

引用0浏览0WOS引用

A Phase 3 Randomized Trial of the Safety and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults ≥ 60 Years of Age in Japan, South Korea, and Taiwan

Miwa Haranaka,Joon Young Song,Kuo-Chin Huang,Richard de Solom,Masako Yamaji,Kathleen McElwee,Mary Kline,Masakazu Aizawa,Yahong Peng,Ingrid Scully,Osamu Kogawara,William C. Gruber,Daniel A. Scott,Wendy Watson

VACCINEno. 5 (2024): 1071-1077

引用0浏览0WOS引用

A Phase 3, Single-Arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age

Jay Meyer,Peter Silas, G. Laissa Ouedraogo,Kathleen McElwee,Georgina Keep,James Trammel,Yahong Peng,Ingrid L. Scully,William C. Gruber,Daniel A. Scott,Wendy Watson

PEDIATRIC INFECTIOUS DISEASE JOURNALno. 6 (2024): 574-581

引用0浏览0WOS引用

A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Shelly Senders,Nicola P. Klein,Noor Tamimi,Allison Thompson,Gary Baugher,James Trammel,Yahong Peng,Peter Giardina,Ingrid L. Scully,Michael Pride,Kimberly J. Center,William C. Gruber,Daniel A. Scott,Wendy Watson

PEDIATRIC INFECTIOUS DISEASE JOURNALno. 6 (2024): 596-603

引用0浏览0WOS引用

A Randomized, Open-Label, Phase 3 Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Chinese Infants and Children under 6 Years of Age

Kai Chu,Yuemei Hu,Hongxing Pan,Jingliang Wu,Dandan Zhu,Mariano M. M. Young Jr, Li Luo, Zhuobiao Yi,Peter C. C. Giardina,William C. C. Gruber,Daniel A. A. Scott,Wendy Watson

Human vaccines & immunotherapeuticsno. 2 (2023)

引用0浏览0WOS引用

Comparison of Pneumococcal Immunogenicity Elicited by the PCV13 and PCV15 Vaccines in Adults 18 Through 49 Years of Age

Isis Kanevsky,Naveen Surendran,Kathleen McElwee,Lanyu Lei,Wendy Watson,Michael Pride,Ingrid Scully, Hatice Karauzum,Annaliesa Anderson,Mariano Young

VACCINEno. 45 (2023): 6625-6629

引用0浏览0WOS引用

1728. Immune Responses to Cross-Reactive Serotypes 6C and 15C after 20-Valent Pneumococcal Conjugate Vaccine in Infants

Noor Tamimi,Mary J Kline,Kimberly J Center,Allison Thompson,Gary Baugher,Jelena Drozd,Ingrid L Scully,Peter Giardina,James Trammel,Lanyu Lei,Yahong Peng,Daniel Scott,William C Gruber,Wendy Watson

Open Forum Infectious Diseasesno. Supplement_2 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn